About the VHIR
Here at the Vall d'Hebron Research Institute (VHIR) we promote biomedical research, innovation and teaching. Over 1,800 people are seeking to understand diseases today so the treatment can be improved tomorrow.
Research
We are working to understand diseases, to find out how they operate and to create better treatments for patients. Get to know about our groups and their lines of research.
People
People are the centre of the Vall d'Hebron Research Institute (VHIR). This is why we are bound by the principles of freedom of research, gender equality and professional attitudes that HRS4R promotes.
Clinical trials
Our work is not just basic or translational; we are leaders in clinical research. Enter and find about the clinical trials we are conducting and why we are a world reference in this field.
Progress
Our aim is to make the research carried out at the Vall d’Hebron Research Institute (VHIR) a driving force for transformation. How? By identifying new channels and solutions for the promotion of people's health and well-being.
Core facilities
We offer specialist support for researchers, internal and external alike, ranging from specific services to preparing complete projects. All this, from a perspective of quality and speed of response.
News
We offer you a gateway for staying up to date on everything going on at the Vall d’Hebron Research Institute (VHIR), from the latest news to future solidarity activities and initiatives that we are organising.
The group of Clinical Neuroimmunology - Centre d'Esclerosi Múltiple de Catalunya (Cemcat) at the Vall d'Hebron Institut de Recerca (VHIR) is a multidisciplinary group dedicated to clinical assistance, physical and cognitive rehabilitation, and clinical and basic research on multiple sclerosis (MS). Cemcat is a national but also an international reference center in the clinical assistance of MS patients. The research performed in the group is divided and further combined in clinical and basic research. In addition, basic research has a marked translational character since the ultimate goal of the group is to improve the quality of life of patients suffering from MS, through in-depth knowledge of the pathogenic mechanisms of the disease and the development of new and more effective therapeutic approaches.
PMID: 38084497 Journal: Multiple Sclerosis Journal Year: 2023 Reference: Mult Scler. 2023 Dec 12:13524585231214362. doi: 10.1177/13524585231214362. Impact factor: Publication type: Paper in international publication Authors: Bailon, Raquel; Buron, Mathias; Comi, Giancarlo; Cummins, Nicholas; Dalla Costa, Gloria; Dobson, Richard; Folarin, Amos; Garcia, Esther; Guerrero, Ana Isabel; Hotopf, Matthew et al. DOI: 10.1177/13524585231214362
PMID: 38183850 Journal: NEUROMUSCULAR DISORDERS Year: 2023 Reference: Neuromuscul Disord. 2023 Dec 14;34:114-122. doi: 10.1016/j.nmd.2023.12.008. Impact factor: Publication type: Other (letters to the editor, abstracts, corrigendum, etc.) Authors: Abiusi, Emanuela; Bertini, Enrico Silvio; Costa-Roger, Mar; de Dios Lascuevas, Marta; Diana, Francesco; Frauenfelder, Giulia; Hernandez, David; Peschillo, Simone; Requena, Manuel; Ribo, Marc et al. DOI: 10.1016/j.nmd.2023.12.008
PMID: 35105687 Journal: Neurology-Neuroimmunology & Neuroinflammation Year: 2022 Reference: Neurol Neuroimmunol Neuroinflamm. 2022 Feb 1;9(2). pii: 9/2/e1143. doi: 10.1212/NXI.0000000000001143. Print 2022 Mar. Impact factor: 8.485 Publication type: Paper in international publication Authors: Arrambide, Georgina; Zabalza, Ana; Nos, Carlos; Sastre-Garriga, Jaume; Tintore, Mar; Montalban, Xavier; Comabella, Manuel; Espejo, Carmen; Castillo, Joaquin; Otero-Romero, Susana et al. DOI: 10.1212/NXI.0000000000001143
PMID: 35139240 Journal: HEMATOLOGICAL ONCOLOGY Year: 2022 Reference: Hematol Oncol. 2022 Feb 9. doi: 10.1002/hon.2976. Impact factor: 5.271 Publication type: Letter or abstract Authors: Barba, Pere; Tintore, Mar; Bosch, Francesc; Cabirta, Alba; Catala, Eva; Iacoboni, Gloria; Vidal-Jordana, Angela; Oristrell, Gerard; Carpio, Cecilia; Vilaseca, Andreu et al. DOI: 10.1002/hon.2976
PMID: 34836608 Journal: REVUE NEUROLOGIQUE Year: 2022 Reference: Rev Neurol (Paris). 2022 Jan-Feb;178(1-2):121-128. doi: 10.1016/j.neurol.2021.10.003. Epub 2021 Nov 4. Impact factor: 2.607 Publication type: Review in international publication Authors: Zabalza, A; Mahdavi, S; Baratian, M; Sedaghat, N; Sepulveda, M; Blanco, Y; Salari, M; Akhavan Sigari, A; Etemadifar, M; Nouri, H et al. DOI: 10.1016/j.neurol.2021.10.003
PMID: 35158476 Journal: Multiple Sclerosis and Related Disorders Year: 2022 Reference: Mult Scler Relat Disord. 2022 Jan;57:103385. doi: 10.1016/j.msard.2021.103385. Epub 2021 Nov 9. Impact factor: 4.339 Publication type: Paper in international publication Authors: Hupperts, Raymond; Langdon, Dawn; Solari, Alessandra; Piehl, Fredrik; Lechner-Scott, Jeannette; Montalban, Xavier; Selmaj, Krzysztof; Valis, Martin; Rejdak, Konrad; Havrdova, Eva K et al. DOI: 10.1016/j.msard.2021.103385
PMID: 33682453 Journal: STROKE Year: 2021 Reference: Stroke. 2021 May;52(5):1751-1760. doi: 10.1161/STROKEAHA.120.031800. Epub 2021 Mar 8. Impact factor: 7.914 Publication type: Paper in international publication Authors: Garcia-Tornel, Alvaro, Campos, Daniel, Rubiera, Marta, Boned, Sandra, Olive-Gadea, Marta, Requena, Manuel, Ciolli, Ludovico, Muchada, Marian, Pagola, Jorge, Deck, Matias et al. DOI: 10.1161/STROKEAHA.120.031800
PMID: 33401136 Journal: NeuroImage-Clinical Year: 2021 Reference: Neuroimage Clin. 2021;29:102549. doi: 10.1016/j.nicl.2020.102549. Epub 2020 Dec 25. Impact factor: 4.881 Publication type: Paper in international publication Authors: Guttmann, Charles R G, Vrenken, Hugo, Uitdehaag, Bernard M J, Burggraaff, Jessica, Liu, Yao, Prieto, Juan C, Simoes, Jorge, de Sitter, Alexandra, Ruggieri, Serena, Brouwer, Iman et al. DOI: 10.1016/j.nicl.2020.102549
PMID: 33328323 Journal: NEUROLOGY Year: 2021 Reference: Neurology. 2021 Jan 26;96(4):e482-e490. doi: 10.1212/WNL.0000000000011339. Epub 2020 Dec 16. Impact factor: 9.91 Publication type: Paper in international publication Authors: Comabella, Manuel, Vidal-Jordana, Angela, Rovira, Alex, Arrambide, Georgina, Otero-Romero, Susana, Rio, Jordi, Galan, Ingrid, Cabello, Sergio, Moncho, Dulce, Rahnama, Kimia et al. DOI: 10.1212/WNL.0000000000011339
PMID: 33436375 Journal: Neurology-Neuroimmunology & Neuroinflammation Year: 2021 Reference: Neurol Neuroimmunol Neuroinflamm. 2021 Jan 12;8(2). pii: 8/2/e941. doi: 10.1212/NXI.0000000000000941. Print 2021 Mar. Impact factor: 8.485 Publication type: Paper in international publication Authors: Brito, Veronica, Fissolo, Nicolas, Matute-Blanch, Clara, Osman, Mohamoud, Costa, Carme, Pinteac, Rucsanda, Miro, Berta, Sanchez, Alex, Khalil, Michael, Borras, Eva et al. DOI: 10.1212/NXI.0000000000000941
PMID: 32700311 Journal: REVISTA DE NEUROLOGIA Year: 2020 Reference: Rev Neurol. 2020 Aug 16;71(4):151-158. doi: 10.33588/rn.7104.2020095. Impact factor: 0.562 Publication type: Review in national publication Authors: Cardenas-Robledo, S, Otero-Romero, S, Montalban, X, Tintore, M et al. DOI: 10.33588/rn.7104.2020095
PMID: 32681355 Journal: Neurotherapeutics Year: 2020 Reference: Neurotherapeutics. 2020 Oct;17(4):1988-2003. doi: 10.1007/s13311-020-00885-8. Impact factor: 6.035 Publication type: Paper in international publication Authors: Castillo, Mireia, Eixarch, Herena, Calvo-Barreiro, Laura, Costa, Carme, Reverter-Vives, Gemma, Montalban, Xavier, Espejo, Carmen, Del Rio, Jose Antonio, Gil, Vanessa et al. DOI: 10.1007/s13311-020-00885-8
PMID: 32676962 Journal: CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY Year: 2020 Reference: Cardiovasc Intervent Radiol. 2020 Nov;43(11):1679-1686. doi: 10.1007/s00270-020-02594-3. Epub 2020 Jul 16. Impact factor: 2.034 Publication type: Paper in international publication Authors: Pinana, Carlos, Gramegna, Laura Ludovica, Folleco, Edgar, Requena, Manuel, Hernandez, David, Tomasello Weitz, Alejandro et al. DOI: 10.1007/s00270-020-02594-3
PMID: 32630765 Journal: International Journal of Environmental Research and Public Health Year: 2020 Reference: Int J Environ Res Public Health. 2020 Jul 2;17(13). pii: ijerph17134774. doi: 10.3390/ijerph17134774. Impact factor: 2.849 Publication type: Paper in international publication Authors: Rasova, Kamila, Martinkova, Patricia, Soler, Bernadita, Freeman, Jenny, Cattaneo, Davide, Jonsdottir, Johanna, Smedal, Tori, Romberg, Anders, Henze, Thomas, Santoyo-Medina, Carme et al. DOI: 10.3390/ijerph17134774
In total, different projects of six research groups will be promoted, focusing on precision medicine and advanced therapies.
Dr. Carmen Espejo and Dr. Georgina Arrambide, researchers at Cemcat and Vall d'Hebron Research Institute, are the first authors of the article.
The research findings propose to modify the McDonald 2017 criteria, only in those in whom diagnosis using the current criteria is not possible.
Simoa HD1 equipment
We are looking for 100 healthy volunteers aged 18 or over to participate in a project where the usefulness of biomarkers in serum will be evaluated to predict the prognosis of the disease and the response to treatments.
